. Author manuscript; available in PMC: 2014 Feb 1.

Published in final edited form as: J Clin Hypertens (Greenwich). 2012 Oct 26;15(2):107–111. doi: 10.1111/jch.12030

Table 2.

Patterns of drug omissions by number of drugs

	1 drug n=57	2 drugs n=38		3 drugs n=25
		1^st drug	2^nd drug	1^st drug	2^nd drug	3^d drug
Single day omissions, n (%)^*^#	35 (61.4)	22 (57.9)	21 (55.3)	15 (60.0)	11 (44.0)	14 (56.0)
DH 2 days, n (%)^*^#	15 (26.3)	8 (21.1)	7 (18.4)	3 (12.0)	3 (12.0)	3 (12.0)
DH 3 days, n (%)^*^#	5 (8.8)	3 (7.9)	8 (21.1)	0	2 (8.0)	2 (8.0)
DH≥4days, n (%)^*^#	16 (28.1)	18 (47.4)	16 (42.1)	5 (20.0)	6 (24.0)	5 (20.0)
Median number of single day omissions per person (range)	1 (0–7)	1 (0–7)	1 (0–6)	1 (0–9)	0 (0–8)	1 (0–8)
Median number of DH2days per person (range)	0 (0–5)	0 (0–4)	0 (0–2)	0 (0–2)	0 (0–1)	0 (0–1)
Median number of DH3days per person (range)	0 (0–1)	0 (0–1)	0 (0–1)	0	0 (0–1)	0 (0–2)
Median number of DH≥4days per person (range)	0 (0–3)	0 (0–4)	0 (0–4)	0 (0–1)	0 (0–4)	0 (0–1)

Total percentage exceeds 100 because some participants have drug omissions of different length

Percentages presented are per drug and not per patient